` Comparison: KYMR vs CANF - Alpha Spread

KYMR
vs
C
CANF

Over the past 12 months, KYMR has significantly outperformed CANF, delivering a return of +194% compared to the CANF's 88% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
KYMR
CANF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

KYMR Intrinsic Value
2.81 USD
Overvaluation 97%
Intrinsic Value
Price
C
CANF Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Kymera Therapeutics Inc
NASDAQ:KYMR
90.08 USD
C
Can Fite Biopharma Ltd
TASE:CANF
718.4 ILS
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
KYMR, CANF

KYMR
CANF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Kymera Therapeutics Inc
Revenue
C
Can Fite Biopharma Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
KYMR, CANF

KYMR
CANF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Kymera Therapeutics Inc
NASDAQ:KYMR
C
Can Fite Biopharma Ltd
TASE:CANF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

KYMR
0%
CANF
0%

Operating Margin

KYMR
-881.2%
CANF
-1 487.2%

Net Margin

KYMR
-794%
CANF
-1 456.2%

FCF Margin

KYMR
-597.6%
CANF
-953.8%

ROE

KYMR
-25.8%
CANF
-382.9%

ROA

KYMR
-22.9%
CANF
-187%

ROIC

KYMR
-50.3%
CANF
-6 189.1%

ROCE

KYMR
-26.9%
CANF
-273.3%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
KYMR, CANF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
KYMR, CANF

Loading
KYMR
CANF
Difference
www.alphaspread.com

Performance By Year
KYMR, CANF

Loading
KYMR
CANF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare KYMR to other stocks
PNEXF
Pharnext SCA
More expensive
vs KYMR
ABBV
Abbvie Inc
Cheaper
vs KYMR
AMGN
Amgen Inc
Cheaper
vs KYMR
GILD
Gilead Sciences Inc
Cheaper
vs KYMR
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett